Metraipolis › archive › dc_4a9ff23fce70
Controlled access to lumasiran in primary hyperoxaluria type 1: evaluation of a new access route for orphan drugs in the Netherlands — Europe PMC PMID:40121182
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40121182
- DOI
- 10.1093/ndt/gfaf060
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T05:03:45.948Z
- SHA-256 of the archived text
1b09ebc5f625c5b772383c3b09a5e8642bf6398bdbca3edc8bb51227cc66c351- Stable URL of this page
https://metraipolis.com/documento/dc_4a9ff23fce70
How to cite
Controlled access to lumasiran in primary hyperoxaluria type 1: evaluation of a new access route for orphan drugs in the Netherlands — Europe PMC PMID:40121182 — Europe PMC (en), https://europepmc.org/article/MED/40121182 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4a9ff23fce70 (Metraipolis archive dc_4a9ff23fce70, sha256 1b09ebc5f625c5b772383c3b09a5e8642bf6398bdbca3edc8bb51227cc66c351)
BibTeX
@misc{dc4a9ff23fce70,
title = {Controlled access to lumasiran in primary hyperoxaluria type 1: evaluation of a new access route for orphan drugs in the Netherlands — Europe PMC PMID:40121182},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40121182},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4a9ff23fce70; sha256 1b09ebc5f625c5b772383c3b09a5e8642bf6398bdbca3edc8bb51227cc66c351},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40121182. Agents can read the archived copy with the MCP tool read_document.